Article Text

Download PDFPDF
Safety and efficacy of a low-cost glaucoma drainage device for refractory childhood glaucoma
  1. Sushmita Kaushik,
  2. Pankaj Kataria,
  3. Srishti Raj,
  4. Surinder Singh Pandav,
  5. Jagat Ram
  1. Advanced Eye Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India
  1. Correspondence to Dr Sushmita Kaushik, Department of Ophthalmology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India; sushmita_kaushik{at}


Background To evaluate the safety and efficacy of a low-cost glaucoma drainage device (GDD), Aurolab aqueous drainage implant (AADI), similar in design to the Baerveldt glaucoma implant (BGI), in refractory childhood glaucoma.

Methods This prospective interventional study was conducted in a tertiary care postgraduate teaching institute. Children aged <16 years with uncontrolled intraocular pressure (IOP) refractory to medical treatment and considered at high risk of failure following trabeculectomy were recruited. Eligible children were implanted with the AADI. Those completing minimum 6-month follow-up were included. Main outcome measures were IOP reduction from preoperative values and postoperative complications.

Results 34 eyes of 31 patients were analysed. Average follow-up was 18.3±6.9 months. Mean IOP reduced from 27.4±7.5 mm Hg on maximum medication to 14.6±10.74 mm Hg, 13.8±7.5 mm Hg, 12.8±5.6 mm Hg and 14.7±5.8 mm Hg at 1 week, 6 months, 1 year (32 eyes of 29 children) and 2 years (25 eyes of 22 children) postoperatively, respectively (p<0.001). The cumulative probability of success was 91.18% at 6 months and 81.7% at 18–24 months. Mean number of topical medications decreased from 3.1±0.6 to 1.8±1.3 at 6 months and 1.6±1.1 at 24 months (p<0.001). Preoperatively, 25 patients required systemic acetazolamide, decreasing to three patients at 2 years. There was no tube erosion or infection. One eye developed retinal detachment.

Conclusion The AADI appears to be a viable low-cost GDD with effectiveness and safety profile comparable with published reports of the BGI and Ahmed glaucoma valve implant in children.

  • Childhood Glaucoma
  • Glaucoma Drainage Device
  • Baerveldt

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors All authors made substantial contributions to the conception or design of the work; or the acquisition,analysis, or interpretation of data for the work. SK accepts full responsibility for the work and/or the conduct of the study, had access to the data and controlled the decision to publish. SK and PK: Drafting the work or revising it critically for important intellectual content. SK and SSP: Final approval of the version to be published. SK, PK, SR, JR: Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

  • Competing interests None declared.

  • Ethics approval Institute Ethics Committee, PGIMER, Chandigarh, India.

  • Provenance and peer review Not commissioned; externally peer reviewed.